University of Chicago Medicine Comprehensive Cancer Center

April is National Cancer Control Month 🎗️ Cigarette smoking remains the leading risk factor for lung cancer. Fortunately, low-dose CT scans offer a powerful tool for early detection—giving high-risk individuals a better chance at life-saving intervention and improved outcomes. 📘 Learn more about lung cancer screening: https://ow.ly/7GW350VyZse #CancerControlMonth #LungCancerAwareness #CancerScreening #LungCancerAwareness #PublicHealth #EarlyDetection

🎗️ April is Head and Neck Cancer Awareness Month Recent research from UChicago Medicine, supported by The National Institutes of Health leveraged AI and single-cell analysis to identify a promising therapeutic target for HPV-related head and neck cancers. This innovative approach brings new hope for more effective, targeted treatments. Read the full story: https://ow.ly/gYO850Vyl6q #HeadAndNeckCancerAwareness #CancerResearch #HPV #Immunotherapy #AIinMedicine The University of Chicago Section of Hematology/Oncology

As MLB Opening Weekend kicks off, we celebrate the impact of philanthropy in advancing cancer research. A generous $500,000 gift from White Sox Charities to UChicago Medicine is supporting groundbreaking work in pancreatic cancer, particularly through CAR T-cell therapy. This innovative treatment offers new hope by targeting cancer cells more precisely, reducing side effects compared to traditional therapies. This collaboration is a powerful reminder of the collective effort to improve patient outcomes and bring transformative treatments to those in need. https://lnkd.in/e-6NFeQH #PancreaticCancer #CARTCellTherapy  #UChicagoMedicine #CancerResearch #WhiteSox 

As MLB Opening Weekend kicks off, we celebrate the impact of philanthropy in advancing cancer research. A generous $500,000 gift from White Sox Charities to UChicago Medicine is supporting groundbreaking work in pancreatic cancer, particularly through CAR T-cell therapy. This innovative treatment offers new hope by targeting cancer cells more precisely, reducing side effects compared to traditional therapies. This collaboration is a powerful reminder of the collective effort to improve patient outcomes and bring transformative treatments to those in need. https://lnkd.in/e-6NFeQH #PancreaticCancer #CARTCellTherapy  #UChicagoMedicine #CancerResearch #WhiteSox 

April is #NationalCancerControlMonth — a crucial time to emphasize the importance of cancer prevention, early detection, and survivorship. At the University of Chicago Medicine Comprehensive Cancer Center, our Cancer Prevention and Control Program is dedicated in understanding the environmental, genetic, psychological, biobehavioral, and economic factors influencing cancer risk and outcomes. Under the leadership of Dr. Brandon Pierce, our multidisciplinary team is committed to translating research findings into effective strategies that benefit our diverse communities. Explore our program: https://ow.ly/gVmQ50Vu4fV #CancerPrevention #CancerResearch #HealthEquity #UChicagoMedicine

April is #HeadAndNeckCancerAwarenessMonth It's time to raise awareness, promote early screenings, and advocate for continued investment in research that can save lives of patients with head and neck cancer. One promising development comes from a recent clinical study conducted by researchers at @UChicagoMedicine. Using a novel combination of chemotherapy and immunotherapy, the researchers showed significant tumor shrinkage in over 50% of patients with advanced HPV-negative head and neck cancer—a subtype that has long posed challenges due to limited treatment options and historically lower survival rates. This breakthrough represents a hopeful step forward in improving outcomes for a patient group that urgently needs more options. Read the full story: https://ow.ly/VRZc50VsJGr #CancerResearch #Immunotherapy #HeadAndNeckCancer #CancerAwareness #ClinicalTrials

Learn about virtual colonoscopy, a less invasive way to screen for colorectal cancer.

We're happy to share more about one of CRF's 2025 Young Investigators, Joseph Franses, MD, PhD. Dr. Franses is an Assistant Professor of Medicine, University of Chicago, and is focusing on circulating tumor cells (CTCs) to discover new blood-based biomarkers and drug targets for hepatocellular carcinoma (HCC), a leading form of liver cancer. While traditional methods focus on circulating free DNA, Dr. Franses is shifting the focus to circulating tumor cells (CTCs)—the precursors to metastasis. CTCs contain crucial RNA and molecular cargo that could reveal deeper insights into how cancer spreads and responds to immune therapies. By studying the interactions between CTCs and immune cells, he hopes to create predictive biomarkers for therapy response and uncover new therapeutic targets, ultimately improving outcomes for HCC patients. This is exciting work CRF is proud to support! Read more about his project at the link below. https://lnkd.in/g8eQjVGz

After being diagnosed with stage 4 non-small cell lung cancer, Brenda Porter received treatment through an National Cancer Institute sponsored clinical trial at UChicago Medicine Ingalls Memorial Hospital. Today, Brenda is back to doing what she loves most: traveling, dancing, and spending time with her family. Her story showcases the promise of innovation, research, and compassionate care in cancer treatment. Read more about Brenda’s inspiring story: https://ow.ly/h2NF50VpZ4n #LungCancer #ClinicalTrials #ClinicalResearch #PatientCare #HealthcareInnovation #CancerSurvivor

After being diagnosed with stage 4 non-small cell lung cancer, Brenda Porter received treatment through an National Cancer Institute sponsored clinical trial at UChicago Medicine Ingalls Memorial Hospital. Today, Brenda is back to doing what she loves most: traveling, dancing, and spending time with her family. Her story showcases the promise of innovation, research, and compassionate care in cancer treatment. Read more about Brenda’s inspiring story: https://ow.ly/h2NF50VpZ4n #LungCancer #ClinicalTrials #ClinicalResearch #PatientCare #HealthcareInnovation #CancerSurvivor